Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Curtsinger

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Transfusion|December 20, 2014
Postthaw characterization of umbilical cord blood: markers of storage lesionAllison Hubel, Ralf Spindler, Julie M Curtsinger, et al.
Seminars in Immunology|March 27, 2007
Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activationMatthew F Mescher, Pujya Agarwal, Kerry A Casey, et al.
American Journal of Clinical Oncology|December 18, 2012
Randomized phase II study of IL-2 with or without an allogeneic large multivalent immunogen vaccine for the treatment of stage IV melanomaGautam Jha, Jeffrey S Miller, Julie M Curtsinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of toleranceAlexander A Filatenkov, Erica L Jacovetty, Ursula B Fischer, et al.
American Journal of Clinical Oncology|April 9, 2008
Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinomaArkadiusz Z Dudek, Matthew F Mescher, Ian Okazaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memoryPujya Agarwal, Arvind Raghavan, Sarada L Nandiwada, et al.
Immunological Reviews|July 11, 2006
Signals required for programming effector and memory development by CD8+ T cellsMatthew F Mescher, Julie M Curtsinger, Pujya Agarwal, et al.
Cancer Immunology, Immunotherapy : CII|December 9, 2017
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cellsVeronika Bachanova, Dhifaf Sarhan, Todd E DeFor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expressionBirgit Sawitzki, Claudio Brunstein, Christian Meisel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivoLisa A E Harmala, Elizabeth G Ingulli, Julie M Curtsinger, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Transfusion|December 20, 2014
Postthaw characterization of umbilical cord blood: markers of storage lesionAllison Hubel, Ralf Spindler, Julie M Curtsinger, et al.
Seminars in Immunology|March 27, 2007
Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activationMatthew F Mescher, Pujya Agarwal, Kerry A Casey, et al.
American Journal of Clinical Oncology|December 18, 2012
Randomized phase II study of IL-2 with or without an allogeneic large multivalent immunogen vaccine for the treatment of stage IV melanomaGautam Jha, Jeffrey S Miller, Julie M Curtsinger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of toleranceAlexander A Filatenkov, Erica L Jacovetty, Ursula B Fischer, et al.
American Journal of Clinical Oncology|April 9, 2008
Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinomaArkadiusz Z Dudek, Matthew F Mescher, Ian Okazaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memoryPujya Agarwal, Arvind Raghavan, Sarada L Nandiwada, et al.
Immunological Reviews|July 11, 2006
Signals required for programming effector and memory development by CD8+ T cellsMatthew F Mescher, Julie M Curtsinger, Pujya Agarwal, et al.
Cancer Immunology, Immunotherapy : CII|December 9, 2017
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cellsVeronika Bachanova, Dhifaf Sarhan, Todd E DeFor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 5, 2013
Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expressionBirgit Sawitzki, Claudio Brunstein, Christian Meisel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivoLisa A E Harmala, Elizabeth G Ingulli, Julie M Curtsinger, et al.
Pageof 3